Startseite Crystal structure of [1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid]-(methylsulfinyl)methane, C15H16N2O6S
Artikel Open Access

Crystal structure of [1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid]-(methylsulfinyl)methane, C15H16N2O6S

  • Hui-Bin Pan , Meng-Qi Tuo , Xia Gao , Jin Liu und Jiu-Fu Lu ORCID logo EMAIL logo
Veröffentlicht/Copyright: 3. September 2024
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 239 Heft 6

Abstract

C15H16N2O6S, monoclinic, P21/n (no. 14), a = 11.1325(3) Å, b = 6.2088(2) Å, c = 23.8080(6) Å, β = 99.266(2)°, V = 1,624.12(8) Å3, Z = 4, Rgt (F) = 0.0431, wRref (F 2) = 0.1271, T = 293(2) K.

CCDC no.: 2343725

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.11 × 0.10 × 0.05 mm
Wavelength: Cu Kα radiation (1.54184 Å)
μ: 2.09 mm−1
Diffractometer, scan mode: XtaLAB Synergy, ω
θ max, completeness: 67.0°, 99 %
N(hkl)measured, N(hkl)unique, R int: 8,883, 2,874, 0.040
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 2,396
N(param)refined: 222
Programs: Bruker 1 , Olex2 2 , SHELX 3 , 4
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
S1 0.76048 (5) 1.60720 (10) 0.63532 (3) 0.0647 (2)
O1 0.75417 (15) −0.1886 (3) 0.28350 (7) 0.0660 (4)
O4 0.84380 (13) 1.1922 (3) 0.53246 (8) 0.0707 (5)
H4 0.831903 1.298642 0.551206 0.106*
O6 0.85163 (13) 1.5173 (3) 0.60028 (7) 0.0673 (5)
N1 0.76860 (14) 0.3610 (2) 0.37305 (6) 0.0416 (4)
N2 0.65978 (13) 0.2873 (3) 0.34829 (6) 0.0447 (4)
O3 0.44095 (15) 0.1443 (3) 0.29501 (8) 0.0829 (6)
O2 0.52639 (16) −0.1382 (4) 0.26279 (9) 0.0908 (7)
H2 0.595412 −0.186745 0.264580 0.136*
O5 0.64328 (15) 1.1869 (4) 0.51509 (11) 0.0980 (7)
C1 0.76390 (16) 0.5524 (3) 0.40702 (7) 0.0411 (4)
C4 0.87441 (17) 0.2592 (3) 0.36670 (8) 0.0458 (4)
H4A 0.947929 0.320162 0.383288 0.055*
C6 0.87647 (18) 0.0735 (3) 0.33728 (8) 0.0460 (4)
C8 0.75008 (17) 0.9179 (3) 0.47296 (8) 0.0441 (4)
C10 0.76277 (18) −0.0156 (3) 0.31102 (8) 0.0481 (5)
C12 0.65721 (18) 0.1105 (3) 0.31846 (8) 0.0473 (5)
C14 0.64754 (18) 0.8386 (3) 0.43882 (9) 0.0524 (5)
H14 0.573187 0.907504 0.438276 0.063*
C15 0.86704 (18) 0.6284 (3) 0.44145 (9) 0.0517 (5)
H15 0.940980 0.557272 0.442838 0.062*
C2 0.65401 (17) 0.6585 (3) 0.40552 (9) 0.0525 (5)
H2A 0.584682 0.608398 0.382102 0.063*
C9 0.73889 (18) 1.1112 (3) 0.50864 (9) 0.0512 (5)
C5 0.85922 (18) 0.8110 (4) 0.47375 (9) 0.0520 (5)
H5 0.928870 0.863103 0.496538 0.062*
C11 0.5306 (2) 0.0432 (4) 0.29110 (9) 0.0623 (6)
C3 0.9923 (2) −0.0384 (4) 0.33024 (11) 0.0617 (6)
H3A 1.059852 0.033875 0.352600 0.093*
H3B 1.001781 −0.035621 0.290877 0.093*
H3C 0.989428 −0.185017 0.342723 0.093*
C13 0.6229 (2) 1.6484 (5) 0.58707 (11) 0.0706 (7)
H13A 0.632999 1.766644 0.562264 0.106*
H13B 0.558284 1.680443 0.608034 0.106*
H13C 0.603157 1.520439 0.564875 0.106*
C7 0.7122 (3) 1.3861 (6) 0.67315 (14) 0.0946 (10)
H7A 0.684606 1.272048 0.646999 0.142*
H7B 0.646784 1.430709 0.692308 0.142*
H7C 0.778947 1.335768 0.700622 0.142*

1 Source of material

Ethyl 1-(4-(ethoxycarbonyl)phenyl)-5-methyl-4-oxo-1,4-dihydropyridazine-3-carboxylate (0.5 mmol) and sodium hydroxide (0.5 mmol) were dissolved in 100 mL deionized water, then added to a 250 mL flask and heated at 333 K for 2 h and cooled to room temperature acidified by addition of 15 % HCl solution until pH = 2, the residue was thoroughly washed, carefully filtered, and subsequently dried, ultimately yielding the desired compound in the form of light yellow crystals.

2 Experimental details

Using Olex2, 2 the structure was solved with the ShelXT 3 structure solution program and refined with the ShelXL 4 refinement package.

3 Comment

Pyridazine derivatives constitute a particularly significant class of biologically active heterocycles. These compounds have garnered considerable attention as ligands due to their remarkable structural and synthetic versatility, precise tunability, and selectivity towards transition metal atoms. 5 Their diverse therapeutic potential, encompassing anticancer, 6 , 7 antidiabetic, 8 , 9 and antibiotic activities, 10 has been extensively documented. Leveraging this understanding, we have achieved the successful synthesis of a novel pyridazine carboxyl derivative, achieved by incorporating a benzene ring adorned with carboxyl groups onto the pyridazine ring. Simultaneously, numerous syntheses of transition metal complexes utilizing this derivative have been documented in various studies. 11 , 12 , 13 , 14 , 15 , 16 However, it is noteworthy that the crystal structure of this pyridazine carboxylic derivative remains unreported thus far.

As shown in Figure 1, this crystal contains two molecules: 1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid and dimethyl sulfoxide. The title target molecule consists of a pyridazine ring and a benzene ring, there are also two carboxyl groups, a carbonyl group and a methyl group on these rings (C4, C6, C10 and C12), the dihedral angles between pyridazine ring and benzene ring is almost complete coplanar, the lengths of nitrogen-nitrogen bond (1.3396) has an intermediate value between typical N–N single (1.45) and N=N double (1.25) bonds, as well as carbon-nitrogen bond lengths, which indicates the delocalization of p-electrons in the molecule. Furthermore, the title molecule and solvent molecule form via stacking interactions and various hydrogen bonds a 3D supramolecular structure.

Figure 1: The asymmetric structural unit of title compound.
Figure 1:

The asymmetric structural unit of title compound.

Corresponding author: Jiu-Fu Lu, Shaanxi Key Laboratory of Catalysis, College of Chemical & Environment Science, Shaanxi University of Technology, Hanzhong, 723001, P.R. China, E-mail:

  1. Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

  3. Research funding: The work was supported by Science and technology innovation project of colleges and universities in Shanxi Province (No. 2023L435).

References

1. BRUKER. SAINT APEX2 and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2009.Suche in Google Scholar

2. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. OLEX2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341. https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

3. Sheldrick, G. M. SHELXTL – Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. 2015, A71, 3–8.10.1107/S2053273314026370Suche in Google Scholar PubMed PubMed Central

4. Sheldrick, G. M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8. https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

5. Chen, S.; Zhang, M. H.; Feng, S.; Gong, C. Y.; Zhou, Y. X.; Xing, L.; He, B. C.; Wu, Y. J.; Xue, W. Design, Synthesis and Biological Activity of Chalcone Derivatives Containing Pyridazine. Arab. J. Chem. 2023, 16, 104852. https://doi.org/10.1016/j.arabjc.2023.104852.Suche in Google Scholar

6. Jaballah, M. Y.; Serya, R. T.; Abouzid, K. Pyridazine Based Scaffolds as Privileged Structures in Anti-Cancer Therapy. Drug Resist. Updates 2017, 67, 138–148. https://doi.org/10.1055/s-0042-119992.Suche in Google Scholar PubMed

7. Kota, T. V. R.; Gandham, H.; Sanasi, P. D. Synthesis, Characterization, and Antidiabetic Activity of 6-Methoxyimidazo [1,2-b] Pyridazine Derivatives. J. Chin. Chem. Soc. 2019, 66, 630–637. https://doi.org/10.1002/jccs.201800332.Suche in Google Scholar

8. Tsuji, T.; Yamaguchi, M.; Kuroyanagi, J.; Furuzono, S.; Konishi, M.; Terayama, K.; Tanaka, J.; Saito, M.; Kobayashi, Y. Discovery of Novel Pyridazine Derivatives as Glucose Transporter Type 4 (GLUT4) Translocation Activators. Bioorg. Med. Chem. Lett. 2019, 29, 1785–1790. https://doi.org/10.1016/j.bmcl.2019.05.013.Suche in Google Scholar PubMed

9. Singh, B.; Bhatia, R.; Pani, B.; Gupta, D. Synthesis, Crystal Structures and Biological Evaluation of New Pyridazine Derivatives. J. Mol. Struct. 2020, 1200, 127084. https://doi.org/10.1016/j.molstruc.2019.127084.Suche in Google Scholar

10. Huang, P. P.; Wu, T. T.; Tuo, M. Q.; Ge, J.; Huang, P.; Wang, W. Q.; Yang, J. P.; Pan, H. B.; Lu, J. F. Supramolecular Complexes of Co(II), Zn(II) and Mn(II) Based on a Pyridazine Dicarboxylic Derivative: Synthesis, Crystal Structures and Properties. J. Mol. Struct. 2024, 1307, 138061. https://doi.org/10.1016/j.molstruc.2024.138061.Suche in Google Scholar

11. Gao, J. H.; Wang, J. X.; Huang, P. P.; Liu, J.; Zheng, N.; Shi, J.; Xu, H. T.; Yue, S. Y.; Lu, J. F. A New Pyrazine Carboxyl Derivative and its Two d10 Metal Coordination Polymers: Syntheses, Characterization, DFT and Property. J. Mol. Struct. 2023, 1290, 135935–135946. https://doi.org/10.1016/j.molstruc.2023.135935.Suche in Google Scholar

12. Gao, J. H.; Huang, P. P.; Liu, J.; Zheng, N.; Wang, D.; Yue, S. Y.; Liu, E. N.; Liu, Q.; Liu, B.; Lu, J. F. Construction of Three Novel Co/Zn/Cd(II) Coordination Polymers Based on the Same Ligands: Different Spatial Structures, Electrocatalysis and Photoluminescence Properties. Arab. J. Chem. 2023, 16, 105314–105330. https://doi.org/10.1016/j.arabjc.2023.105314.Suche in Google Scholar

13. Gao, J. H.; Huang, P. P.; Zhang, Z. J.; Tian, F. W.; Ge, J.; Cao, X. Y.; Liu, J.; Wang, D.; Zheng, N.; Lu, J. F.; Liu, B. A New 3D Cd-MOF with 2fold Interpenetrated as “Turn-On/Turn-Off” Fluorescent Sensor for Selective and Sensitive Detection of Cu2+, Al3+ and Fe3+ Ions. J. Mol. Struct. 2024, 1299, 137162–137171. https://doi.org/10.1016/j.molstruc.2023.137162.Suche in Google Scholar

14. Pan, H. B.; Gao, J. H.; Huang, P. P.; Wang, J. X.; Wu, T. T.; Lu, J. F. Crystal Structure of Hexaaquazinc(II) catena-poly[bis(1-(3-Carboxyphenyl)-5-methyl-4-oxo-1,4-dihydropyridazine-3-carboxylato-κ2O,O′)-bis(μ2-1-(3-carboxyphenyl)-5-methyl-4-oxo-1,4-dihydropyridazine-3-carboxylato-κ2O:O′)trizinc(II)] Hexahydrate C26H36N4O20Zn2. Z. Kristallogr. N. Cryst. Struct. 2024, 239, 159–161. https://doi.org/10.1515/ncrs-2023–0398.10.1515/ncrs-2023-0398Suche in Google Scholar

15. Zhao, J.; Liu, M. L.; Guo, S. B.; Sun, M.; Zheng, J. L.; Ma, S. T.; Lu, J. F.; Ge, H. G. Two Cu(II) Complexes Constructed by Pyridazine Carboxyl Derivatives: Synthesis, Crystal Structure and Property. Inorg. Nano-Met. Chem. 2021, 239, 1952247. https://doi.org/10.1080/24701556.2021.1952247.Suche in Google Scholar

16. Liu, W. J.; Wang, D. F.; Cao, X.; Wang, Q. W.; Shen, L. G. Crystal Structure of catena-poly[Triaqua-(μ2-1-(4-Carboxylatophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylato-O,O′:O″) cobalt(II)], C12H12N2O8Co. Z. Kristallogr. N. Cryst. Struct. 2024, 239, 121–123. https://doi.org/10.1515/ncrs-2023–0465.10.1515/ncrs-2023-0465Suche in Google Scholar
Received: 2024-06-24
Accepted: 2024-08-23
Published Online: 2024-09-03
Published in Print: 2024-12-17

© 2024 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of 3-nitrophenol-2,1,3-benzoselenadiazole (1/1), C12H9N3O3Se
  4. Crystal structure of diaqua-(hydroxido)-{μ-[2-(hydroxy)-5-[(4-nitrophenyl)diazenyl]benzoato]}-{2-hydroxy-5-[(4-nitrophenyl)diazenyl]benzoato}-(1,10-phenanthroline)-diterbium hydrate, C38H27.4N8O12.2Tb
  5. Crystal structure of poly[bis(μ3-3-fluoro-4-(1H-1,2,4-triazol-1-yl)benzoato-κ3 O:O′:N)cadmium(II)] – dimethylformamide (1/1), C21H17CdF2N7O5
  6. The crystal structure of 2-amino-N-(pyridin-2-yl)benzamide, C12H11N3O
  7. The crystal structure of 2,3-di(pyridin-2-yl)-2,3-dihydroquinazolin-4(1H)-one, C18H14N4O
  8. Crystal structure of 2-chloro-4-fluorobenzyl (R)-2-(6-methoxynaphthalen-2-yl)propanoate, C21H18ClFO3
  9. Crystal structure of [1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid]-(methylsulfinyl)methane, C15H16N2O6S
  10. The crystal structure of 2-ethyl-1,1-dimethyl-1H-benzo[e]indole, C16H17N
  11. The crystal structure of (Z)-5-amino-N ′-hydroxy-1H-pyrazole-4-carboximidamide, C4H7N5O
  12. The crystal structure of 2,2,5-trimethyl-3-(4-(4-(5-phenyl-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)phenyl)imidazolidin-4-one, C24H24N4O2S
  13. The crystal structure of tetrakis(μ2-acetato-κ2 O:O′)-bis[(4′-phenyl-4,2′:6′,4″-terpyridine-κ1 N)dicopper(II)], C25H21CuN3O4
  14. Crystal structure of poly(3-thiophenecarboxylato-κ 3 O,O′:O′)-(methanol-κO)cadmium(II), C11H10O5S2Cd
  15. The crystal structure of dichloridobis[4′-(p-methoxylphenyl)-4,2′:6′,4″-terpyridine-κN] zinc(II), C44H34Cl2N6O2Zn
  16. The crystal structure of 1-(2-carboxyethyl)-1H-imidazole 3-oxide
  17. Crystal structure of 1,1′,1″-(nitrilotris(ethane-2,1-diyl))tris(3-(4-(((E)-pyridin-2-ylmethylene)amino)phenyl)urea), C45H47N13O4
  18. Crystal structure of a (E)-4-bromo-N-(4-(diethylamino)-2-hydroxybenzylidene) benzenaminium acetate ─ 4-bromoaniline (1/1)
  19. Crystal structure of 2,2′-(iminobis(methylene))bis(benzimidazolium) bis(p-toluenesulfonate), C30H31N5O6S2
  20. The crystal structure of alogliptinium meta-chlorobenzoate
  21. Crystal structure of 4-bromobenzyl 2-(6-methoxy-naphthalen-2-yl)propanoate, C21H19BrO3
  22. The hydrated double salt structure of (E)-4-(2-benzylidenehydrazine-1-carbonyl)pyridin-1-ium cation with 2-hydroxybenzoate and benzoate anions
  23. Crystal structure of (R)(R)-5-chloro-3-((S,1E,3E)-3,5-dimethyl-hepta-1,3-dien-1-yl)-7-methyl-6,8-dioxo-2,6,7,8-tetrahydroisoquinolin-7-yl acetate, C21H24ClNO4
  24. The crystal structure of bis(3-oxo-1,3-diphenylprop-1-en-1-olato-κ 2 O:O′)-bis(1,4-dioxane-κ 1 O)nickel(II), C38H38O8Ni
  25. Crystal structure of poly[aqua-(pyridine-3-carboxylato-κ1 N)(pyridine-3-carboxylato-κ2 O,O′) cadmium(II)] dihydrate, C12H14N2O7Cd
  26. The crystal structure of 4-(4-phenyl-5-(((1-(2,4,6-tribromophenyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-4H-1,2,4-triazol-3-yl)pyridine, C22H14Br3N7S
  27. The crystal structure of N-benzylquinoline-2-carbothioamide, C17H14N2S
  28. Crystal structure of bis(3-isopropylphenyl)-4,4′-bipyridinium dichloride dihydrate, C28H30N2⋅2Cl⋅2H2O
  29. The crystal structure of ethyl 2-amino-4-(cyanophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C19H18N2O4
  30. Crystal structure of (4R,10S)-6-hydroxy-7-isopropyl-4,10-dimethyl-1,2,3,5-hexahydro-6,10-epoxyazulen-9-one, C15H22O3
  31. The crystal structure of (E)-(2-(2-hydroxy-3-methoxybenzylidene)aminophenyl)arsonic acid, C14H14AsNO5
  32. The crystal structure of poly[(μ 2-2-aminoisophthalato-κ4O,O′:O″:O″′)-(N-methylpyrrolidone κ1O)-dioxido-uranium(VI)], C13H14N2O7U
  33. The crystal structure of the co-crystal isonicotinamide · terephthalic acid, C8H6O4·2(C6H6N2O)
  34. The crystal structure of (E)-1-phenyl-3-(p-tolylthio)but-2-en-1-one, C17H16OS
  35. The crystal structure of 4,5-bis((Z)-chloro(hydroxyimino)methyl)-1H-imidazol-3-ium chloride monohydrate
  36. The crystal structure of 1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-dione. C18H20N2O2
  37. Crystal structure of 2-chloro-4-fluorobenzyl 2-acetoxybenzoate, C16H12ClFO4
  38. Crystal structure of methyl 1-phenyl-9H-pyrido[3,4-b]indole-3-carboxylate, C19H14N2O2
  39. Crystal structure of (3-(dimethoxymethyl)-5-methoxy-1H-indol-1-yl)(5-fluoro-2-iodophenyl)methanone, C19H17FINO4
  40. Crystal structure of tetrachlorido-bis(1-[(1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2 N:N′)dicopper, C36H32Cu2N24Cl4
  41. Crystal structure of 2-(2,3-bis(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoxalin-1-yl)anilin, C30H24N4O2
  42. Crystal structure of 5,7-dihydroxy-2-phenyl-4H-chromen-4-one–N,N-dimethylformamide(1/1), C18H17NO5
  43. The crystal structure of bis(μ 2-biphenyl-2,2′-dicarboxylato)-diaqua-bis(nitrato)-bis(2,2′:6′,2′′-terpyridine)dineodymium(III), C46H32I2N8Nd2O16
  44. Crystal structure of (Z)-4-amino-N ′-((4-chlorophenyl)(phenyl)methylene)benzohydrazide, C20H16ClN3O
  45. Crystal structure of (E)-6,8-dimethoxy-4-(4-morpholinobenzylidene)-3,4-dihydro-1-benzoxepin-5(2H)-one, C23H25NO5
  46. Crystal structure of (R)-2-((3-(3-aminopiperidin-1-yl)-6-methyl-5-oxo-1,2,4-triazin-4(5H)-yl) methyl)-4-fluorobenzonitrile benzoate monohydrate, C24H27FN6O4
  47. The crystal structure of [triaqua-(8-carboxymethoxy-quinoline-2-carboxylato-κ 3 N,O,O)copper(II)]monohydrate, C12H15NO9Cu
  48. Crystal structure of (((4-chlorophenyl)sulfonyl)glycinato-κ 2 N,O)bis(1,10-phenanthroline-κ 2 N,N′)cobalt(II) tetrahydrate, C32H30ClCoN5O8S
  49. Crystal structure of (((3-nitrophenyl)sulfonyl)-β-alaninato-κO)bis(2,2′-bipyridine-κ 2 N, N′)copper(II) 3-nitrobenzenesulfonate, C35H29CuN7O11S2
  50. Crystal structure of 3-phenoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C27H24O4
  51. 6-(2′,3′-Dihydroxy-3′-methylbutyl)-7-methoxy-8-(3″-methylbut-2″-en-1″-yl)-2H-chromen-2-one, C20H26O5
  52. Crystal structure of bromido-(2,2′:6′,2″-terpyridine-4′-onato-κ3N)palladium(II) methanol solvate
  53. The crystal structure of ethyl 2-amino-(4-nitrophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C20H22N2O6
  54. Crystal structure of (1E,3E,5E)-1,6-bis(4-(pentyloxy)phenyl)hexa-1,3,5-triene, C28H36O2
  55. The crystal structure of tris(2-bromo-4-methylphenyl)amine, C21H18Br3N
  56. The crystal structure of 3-(2,5-dimethylanilino)-1-(2,5-dimethylphenyl)-4-methyl-1H-pyrrole-2,5-dione, C21H22N2O2
  57. Crystal structure of dicarbonyl (μ2-indole-2-carboxylato κ2 O:O′)tris(triphenylarsine-κAs)dirhodium(I) acetone solvate, C68H56As3NO5Rh2
  58. The crystal structure of 4-chloro-2-formylphenyl 4-methylbenzenesulfonate, C14H11ClO4S
  59. Crystal structure of 4-iodobenzyl 2-(6-methoxynaphthalen-2-yl) propanoate, C21H19IO3
https://doi.org/10.1515/ncrs-2024-0260
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of 3-nitrophenol-2,1,3-benzoselenadiazole (1/1), C12H9N3O3Se
  4. Crystal structure of diaqua-(hydroxido)-{μ-[2-(hydroxy)-5-[(4-nitrophenyl)diazenyl]benzoato]}-{2-hydroxy-5-[(4-nitrophenyl)diazenyl]benzoato}-(1,10-phenanthroline)-diterbium hydrate, C38H27.4N8O12.2Tb
  5. Crystal structure of poly[bis(μ3-3-fluoro-4-(1H-1,2,4-triazol-1-yl)benzoato-κ3 O:O′:N)cadmium(II)] – dimethylformamide (1/1), C21H17CdF2N7O5
  6. The crystal structure of 2-amino-N-(pyridin-2-yl)benzamide, C12H11N3O
  7. The crystal structure of 2,3-di(pyridin-2-yl)-2,3-dihydroquinazolin-4(1H)-one, C18H14N4O
  8. Crystal structure of 2-chloro-4-fluorobenzyl (R)-2-(6-methoxynaphthalen-2-yl)propanoate, C21H18ClFO3
  9. Crystal structure of [1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid]-(methylsulfinyl)methane, C15H16N2O6S
  10. The crystal structure of 2-ethyl-1,1-dimethyl-1H-benzo[e]indole, C16H17N
  11. The crystal structure of (Z)-5-amino-N ′-hydroxy-1H-pyrazole-4-carboximidamide, C4H7N5O
  12. The crystal structure of 2,2,5-trimethyl-3-(4-(4-(5-phenyl-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)phenyl)imidazolidin-4-one, C24H24N4O2S
  13. The crystal structure of tetrakis(μ2-acetato-κ2 O:O′)-bis[(4′-phenyl-4,2′:6′,4″-terpyridine-κ1 N)dicopper(II)], C25H21CuN3O4
  14. Crystal structure of poly(3-thiophenecarboxylato-κ 3 O,O′:O′)-(methanol-κO)cadmium(II), C11H10O5S2Cd
  15. The crystal structure of dichloridobis[4′-(p-methoxylphenyl)-4,2′:6′,4″-terpyridine-κN] zinc(II), C44H34Cl2N6O2Zn
  16. The crystal structure of 1-(2-carboxyethyl)-1H-imidazole 3-oxide
  17. Crystal structure of 1,1′,1″-(nitrilotris(ethane-2,1-diyl))tris(3-(4-(((E)-pyridin-2-ylmethylene)amino)phenyl)urea), C45H47N13O4
  18. Crystal structure of a (E)-4-bromo-N-(4-(diethylamino)-2-hydroxybenzylidene) benzenaminium acetate ─ 4-bromoaniline (1/1)
  19. Crystal structure of 2,2′-(iminobis(methylene))bis(benzimidazolium) bis(p-toluenesulfonate), C30H31N5O6S2
  20. The crystal structure of alogliptinium meta-chlorobenzoate
  21. Crystal structure of 4-bromobenzyl 2-(6-methoxy-naphthalen-2-yl)propanoate, C21H19BrO3
  22. The hydrated double salt structure of (E)-4-(2-benzylidenehydrazine-1-carbonyl)pyridin-1-ium cation with 2-hydroxybenzoate and benzoate anions
  23. Crystal structure of (R)(R)-5-chloro-3-((S,1E,3E)-3,5-dimethyl-hepta-1,3-dien-1-yl)-7-methyl-6,8-dioxo-2,6,7,8-tetrahydroisoquinolin-7-yl acetate, C21H24ClNO4
  24. The crystal structure of bis(3-oxo-1,3-diphenylprop-1-en-1-olato-κ 2 O:O′)-bis(1,4-dioxane-κ 1 O)nickel(II), C38H38O8Ni
  25. Crystal structure of poly[aqua-(pyridine-3-carboxylato-κ1 N)(pyridine-3-carboxylato-κ2 O,O′) cadmium(II)] dihydrate, C12H14N2O7Cd
  26. The crystal structure of 4-(4-phenyl-5-(((1-(2,4,6-tribromophenyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-4H-1,2,4-triazol-3-yl)pyridine, C22H14Br3N7S
  27. The crystal structure of N-benzylquinoline-2-carbothioamide, C17H14N2S
  28. Crystal structure of bis(3-isopropylphenyl)-4,4′-bipyridinium dichloride dihydrate, C28H30N2⋅2Cl⋅2H2O
  29. The crystal structure of ethyl 2-amino-4-(cyanophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C19H18N2O4
  30. Crystal structure of (4R,10S)-6-hydroxy-7-isopropyl-4,10-dimethyl-1,2,3,5-hexahydro-6,10-epoxyazulen-9-one, C15H22O3
  31. The crystal structure of (E)-(2-(2-hydroxy-3-methoxybenzylidene)aminophenyl)arsonic acid, C14H14AsNO5
  32. The crystal structure of poly[(μ 2-2-aminoisophthalato-κ4O,O′:O″:O″′)-(N-methylpyrrolidone κ1O)-dioxido-uranium(VI)], C13H14N2O7U
  33. The crystal structure of the co-crystal isonicotinamide · terephthalic acid, C8H6O4·2(C6H6N2O)
  34. The crystal structure of (E)-1-phenyl-3-(p-tolylthio)but-2-en-1-one, C17H16OS
  35. The crystal structure of 4,5-bis((Z)-chloro(hydroxyimino)methyl)-1H-imidazol-3-ium chloride monohydrate
  36. The crystal structure of 1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-dione. C18H20N2O2
  37. Crystal structure of 2-chloro-4-fluorobenzyl 2-acetoxybenzoate, C16H12ClFO4
  38. Crystal structure of methyl 1-phenyl-9H-pyrido[3,4-b]indole-3-carboxylate, C19H14N2O2
  39. Crystal structure of (3-(dimethoxymethyl)-5-methoxy-1H-indol-1-yl)(5-fluoro-2-iodophenyl)methanone, C19H17FINO4
  40. Crystal structure of tetrachlorido-bis(1-[(1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2 N:N′)dicopper, C36H32Cu2N24Cl4
  41. Crystal structure of 2-(2,3-bis(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoxalin-1-yl)anilin, C30H24N4O2
  42. Crystal structure of 5,7-dihydroxy-2-phenyl-4H-chromen-4-one–N,N-dimethylformamide(1/1), C18H17NO5
  43. The crystal structure of bis(μ 2-biphenyl-2,2′-dicarboxylato)-diaqua-bis(nitrato)-bis(2,2′:6′,2′′-terpyridine)dineodymium(III), C46H32I2N8Nd2O16
  44. Crystal structure of (Z)-4-amino-N ′-((4-chlorophenyl)(phenyl)methylene)benzohydrazide, C20H16ClN3O
  45. Crystal structure of (E)-6,8-dimethoxy-4-(4-morpholinobenzylidene)-3,4-dihydro-1-benzoxepin-5(2H)-one, C23H25NO5
  46. Crystal structure of (R)-2-((3-(3-aminopiperidin-1-yl)-6-methyl-5-oxo-1,2,4-triazin-4(5H)-yl) methyl)-4-fluorobenzonitrile benzoate monohydrate, C24H27FN6O4
  47. The crystal structure of [triaqua-(8-carboxymethoxy-quinoline-2-carboxylato-κ 3 N,O,O)copper(II)]monohydrate, C12H15NO9Cu
  48. Crystal structure of (((4-chlorophenyl)sulfonyl)glycinato-κ 2 N,O)bis(1,10-phenanthroline-κ 2 N,N′)cobalt(II) tetrahydrate, C32H30ClCoN5O8S
  49. Crystal structure of (((3-nitrophenyl)sulfonyl)-β-alaninato-κO)bis(2,2′-bipyridine-κ 2 N, N′)copper(II) 3-nitrobenzenesulfonate, C35H29CuN7O11S2
  50. Crystal structure of 3-phenoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C27H24O4
  51. 6-(2′,3′-Dihydroxy-3′-methylbutyl)-7-methoxy-8-(3″-methylbut-2″-en-1″-yl)-2H-chromen-2-one, C20H26O5
  52. Crystal structure of bromido-(2,2′:6′,2″-terpyridine-4′-onato-κ3N)palladium(II) methanol solvate
  53. The crystal structure of ethyl 2-amino-(4-nitrophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C20H22N2O6
  54. Crystal structure of (1E,3E,5E)-1,6-bis(4-(pentyloxy)phenyl)hexa-1,3,5-triene, C28H36O2
  55. The crystal structure of tris(2-bromo-4-methylphenyl)amine, C21H18Br3N
  56. The crystal structure of 3-(2,5-dimethylanilino)-1-(2,5-dimethylphenyl)-4-methyl-1H-pyrrole-2,5-dione, C21H22N2O2
  57. Crystal structure of dicarbonyl (μ2-indole-2-carboxylato κ2 O:O′)tris(triphenylarsine-κAs)dirhodium(I) acetone solvate, C68H56As3NO5Rh2
  58. The crystal structure of 4-chloro-2-formylphenyl 4-methylbenzenesulfonate, C14H11ClO4S
  59. Crystal structure of 4-iodobenzyl 2-(6-methoxynaphthalen-2-yl) propanoate, C21H19IO3
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2024-0260/html?srsltid=AfmBOoqA7YYniO470c1GcuceodhpsS7YcmLE5EwL5YFrbo6nqghZTmXd
Button zum nach oben scrollen